Does Cigna Medicare Cover Wegovy? Medicare Advantage Coverage Guide 2026
If you’re enrolled in on Cigna Medicare Advantage (managed by Cigna Healthcare) commonly wonder whether the formulary covers Wegovy (semaglutide 2.4mg). Here’s the overview: coverage depends on specific formulary placement and clinical criteria.
Cigna Medicare’s Formulary Position on Wegovy
Cigna Medicare Advantage operates with a Part D formulary that classifies medications into cost-sharing tiers. For the 2026 plan year, Wegovy is generally listed at Tier 5 (Specialty) for typical Cigna Medicare plan variants.
What this means for you:
- Monthly copay: $100–$300+ based on plan variant and drug tier
- Prior authorization: Required — clinical documentation must be provided
- Quantity limits: May apply — typically one pen/month
- Step therapy: May require failed trial of metformin, insulin, or other treatments first
Note that the coverage gap, enrollees pay a larger share until reaching the catastrophic threshold.
Coverage for Diabetes vs. Weight Loss
For chronic weight management (FDA-approved):
- Cigna Medicare will generally cover Wegovy for on-label use
- Required evidence: lab work and prescription history
- Approval rates are higher when used on-label
For weight loss (where applicable):
- CMS policy generally prohibits anti-obesity medications from formulary coverage
- However: recent CMS guidance expanded what Medicare Advantage plans can cover for certain anti-obesity drugs
- Cigna Medicare may offer enhanced coverage that extend to weight management medications — call Cigna Healthcare member services
How Much Does Wegovy Cost With Cigna Medicare
Calculating your actual cost for Wegovy on Cigna Medicare requires knowing where you are in the benefit structure.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($590 in 2026) | Full retail price: $1,300–$1,500/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | Significant coinsurance |
| Catastrophic Coverage | Minimal cost |
The IRA’s $2,000 annual cap, out-of-pocket Part D spending is capped at $2,000/year — a major benefit for patients on expensive specialty drugs.
How to Maximize Coverage
- Request a formulary exception — If Wegovy is non-preferred, your provider can request a tier reduction or formulary exception with clinical justification
- Check manufacturer support — Novo Nordisk runs patient assistance programs for qualifying patients (eligibility varies)
- Compare plans during open enrollment — Open enrollment (Oct 15–Dec 7) is your chance to switch to a plan with better Wegovy coverage
- Check Low-Income Subsidy eligibility — Low-income beneficiaries can receive LIS benefits that slash out-of-pocket expenses